Liver disease is a serious public health issue in Taiwan. The Liver Disease Prevention and Treatment Research Foundation, Taiwan, is one of Asia’s most active and successful patient advocacy groups. Learn from Professor Yang Pei-Ming, CEO of the foundation, about their work and the importance of clinical lab diagnostics to their mission….
Cancer Type: Liver
Liver Cancer in Japan: Dr Shun Kaneko on HCC Screening and Surveillance
Japan is a global leader in hepatocellular carcinoma (HCC) surveillance, with an effective programme that enables early-stage carcinomas detection. Yet unmet needs continue to affect the management of HCC. Learn from Dr Shun Kaneko on Japan’s progress and challenges in HCC management. …
HCC in Thailand: Dr Terachai Songkiatkawin on Improving Liver Cancer Diagnostics and Treatment
More than 27,000 patients in Thailand are found to have liver cancer each year, making it the most-frequently diagnosed cancer in the country. With emerging risk factors, such as alcohol consumption, managing liver disease continues to be a serious challenge for the Thai Ministry of Public Health (MoPH). Learn from Dr Terachai Songkiatkawin, a surgical oncologist and co-president of the MoPH’s cancer service plan, on the policy trends and strategies for improving liver cancer care in Thailand….
Tackling HCV in Punjab: local experts share strategies for success
Punjab is one of Pakistan’s largest provinces and has a particularly high HCV prevalence rate of roughly 9%, compared to 5.4% for Pakistan’s total population. Hear from Prof Ghias Un Nabi Tayyab and Prof Muhammad Umar, two leading experts on HCV in pUnjab, and active participants in Pakistan’s HCV programmes, as they share their perspectives on Punjab’s HCV eradication efforts and solutions for local challenges. …
Strengthening healthcare systems through the critical role of diagnostics
In line with the WHO Essential Diagnostics List (EDL) and Lancet Commission efforts, the Asia Pacific Medical Technology Association and its members recently came together to produce an inaugural paper about the value delivered by diagnostic technologies in the Asia Pacific region.
In this session, learn about the latest insights from public-private dialogue on improving the value recognition of diagnostic technologies by governments and payers in the region.
…
Pakistan’s national HCV elimination programme: insights from Dr Huma Qureshi
In 2019, Pakistan announced a nationwide programme to scale up HCV prevention, testing and treatment. Hear from gastroenterologist Dr Huma Qureshi, a key figure in Pakistan’s national HCV program, as she shares her thoughts on best practices for screening and elimination across the region. …